Regular ArticleBacteraemia due to Stenotrophomonas maltophilia: An Analysis of 45 Episodes☆
References (23)
- et al.
Stenotrophomonas maltophilia bacteraemia in cancer patients: report on 31 cases
J Hosp Infect
(1996) - et al.
Review of adverse experiences and tolerability in the first 2,516 patients treated with imipenen/cilastatin
Am J Med
(1985) - et al.
The antibiotic susceptibilities of Xanthomonas maltophilia and their relation to clinical management
Pathology
(1994) - et al.
Bacteraemia caused by non- aeruginosa Pseudomonas species in a cancer centre
J Hosp infect
(1992) - et al.
Antimicrobial activity of 12 broad-spectrum agents tested against 270 nosocomial blood stream infection isolates caused by non-enteric gram-negative bacilli: occurrence of resistance, molecular epidemiology, and screening for metallo-enzymes
Diagn Microbiol Infect Dis
(1997) - et al.
Infections caused by Pseudomonas maltophilia: expanding clinical spectrum
Arch Intern Med
(1987) - et al.
Bacteremia due to Stenotrophomonas (Xanthomonas) maltophilia: A prospective, Multicenter Study of 91 episodes
Clin Infect Dis
(1996) - et al.
Septicemia due to Xanthomonas Species and Non-Aeruginosa Pseudomonas Species: Increasing incidence of catheter-related infections
Medicine
(1990) - et al.
Xanthomonas maltophilia Bacteremia in Immunocompromised Hematological Patients
Scand J Infect Dis
(1994) - Turnidge, J, Stockman, K, Antimicrobial susceptibility testing. Clinical microbiology update programme, Australian...
Assessment of antibiotic-sensitive, intermediate or resistant status of bacteria by agar dilution
Med Lab Sci
Cited by (138)
In which cases of pneumonia should we consider treatments for Stenotrophomonas maltophilia?
2021, Journal of Hospital InfectionCitation Excerpt :This means that the immune status of the host is a distinguishing factor that will lead to either infection and/or colonization. It has long been reported that S. maltophilia infections occur in people with poor immune status [1,19,21–25], and underlying diseases and steroids are heavily involved in immunosuppression. Pre-administration of an anticancer drug may be associated with immunosuppression.
Diversity of L1/L2 genes and molecular epidemiology of high-level carbapenem resistance Stenotrophomonas maltophilia isolates from animal production environment in China
2020, Infection, Genetics and EvolutionCitation Excerpt :The L1 structure includes a coordinating Zn2+ involved in the formation of a metal acceptor bond with the lactam oxygen and the carboxyl oxygen of antibiotics. Even though S. maltophilia is not a highly virulent pathogen, its associated crude mortality rates range from 14 to 69% in bacteremic patients (Adegoke et al., 2017; Alessandra Micozzi et al., 2000; Brooke, 2012; Cho et al., 2015; Friedman et al., 2002). This is most likely the result of its ability to colonize respiratory-tract epithelial cells and generate biofilms on medical device surfaces and this is reflected in its ability to cause nosocomial infections.
Fluoroquinolones versus trimethoprim-sulfamethoxazole for the treatment of Stenotrophomonas maltophilia infections: a systematic review and meta-analysis
2019, Clinical Microbiology and InfectionRisk factors for death from Stenotrophomonas maltophilia bacteremia
2018, Journal of Infection and ChemotherapyCitation Excerpt :Some potential risk factors were not included due to lack of sepsis-related scoring data such as SOFA score or APACHE II score. Also, the study duration is shorter than for some other reports [7,20,21]. Continuing evaluation of trends in death by nosocomial S. maltophilia bacteremia and larger prospective studies with greater patient numbers are warranted.
Clinical impact of delayed catheter removal for patients with central-venous-catheter-related Gram-negative bacteraemia
2018, Journal of Hospital Infection
- ☆
Please address all correspondence to: N. D. Friedman, Infectious Diseases Fellow, Division of Infectious Diseases and International Health, Box 3824, Duke University Medical Center, Durham, NC 27710, USA. Tel.: +9196842660 Fax: +919–6817945; E-mail address: [email protected] (N. D. Friedman).